TECOGEN INC. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by TECOGEN INC. on November 6, 2013, regarding a material definitive agreement entered into on the same date. The company is incorporated in Delaware with principal executive offices in Waltham, Massachusetts.
Key Financial Metrics
The filing details a private placement transaction rather than periodic financial performance metrics. Key transaction figures include:
- Shares Sold: 236,111 shares of common stock ($0.001 par value).
- Price Per Share: $4.50.
- Aggregate Proceeds: $1,062,500.
- Transaction Fees: $71,719 (6.75% of gross proceeds) payable to investment banks.
The filing text does not provide clear values for revenue, profit, cash flow, margins, debt, or liquidity outside of this specific transaction.
Material Changes
The primary material change is the increase in equity capital through the sale of unregistered securities to four accredited investors. Proceeds are designated for repaying amounts owed to the Chief Executive Officer, John Hatsopoulos, and for general corporate and working capital purposes.
Outlook, Risks, and Unusual Items
Registration Requirement: The Company is required to file a registration statement with the SEC covering the resale of the shares by the investors.
Restrictions: The shares were sold in reliance on Section 4(a)(2) and Rule 506 exemptions. They may not be re-offered or sold in the United States absent an effective registration statement or applicable exemption.
Management Commentary: No forward-looking guidance or outlook was provided in this filing.
Investor Verification Checklist
- Verify the status of the registration statement required for the resale of the 236,111 shares.
- Confirm the specific amounts owed to CEO John Hatsopoulos that are being repaid with these proceeds.
- Review the full text of the Common Stock Purchase Agreement (Exhibit 10.1) for additional covenants or restrictions.
- Assess the impact of the $71,719 fee on net capital raised.